These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29221130)

  • 21. Codelivery of anti-cancer agents via double-walled polymeric microparticles/injectable hydrogel: A promising approach for treatment of triple negative breast cancer.
    Davoodi P; Ng WC; Srinivasan MP; Wang CH
    Biotechnol Bioeng; 2017 Dec; 114(12):2931-2946. PubMed ID: 28832946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer.
    Imamura Y; Mukohara T; Shimono Y; Funakoshi Y; Chayahara N; Toyoda M; Kiyota N; Takao S; Kono S; Nakatsura T; Minami H
    Oncol Rep; 2015 Apr; 33(4):1837-43. PubMed ID: 25634491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AlgiMatrix™-Based 3D Cell Culture System as an In Vitro Tumor Model: An Important Tool in Cancer Research.
    Godugu C; Singh M
    Methods Mol Biol; 2016; 1379():117-28. PubMed ID: 26608295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eribulin upregulates miR-195 expression and downregulates Wnt3a expression in non-basal-like type of triple-negative breast cancer cell MDA-MB-231.
    Furuya K; Sasaki A; Tsunoda Y; Tsuji M; Udaka Y; Oyamada H; Tsuchiya H; Oguchi K
    Hum Cell; 2016 Apr; 29(2):76-82. PubMed ID: 26573286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticancer SAR models for MCF-7 and MDA-MB-231 breast cell lines.
    Qamar S; Carrasquer CA; Cunningham SL; Cunningham AR
    Anticancer Res; 2011 Oct; 31(10):3247-52. PubMed ID: 21965732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative Evaluation of the Cytotoxicity of Doxorubicin in BT-20 Triple-Negative Breast Carcinoma Monolayer and Spheroid Cultures.
    Ncube KN; Jurgens T; Steenkamp V; Cromarty AD; van den Bout I; Cordier W
    Biomedicines; 2023 May; 11(5):. PubMed ID: 37239157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis, Crystal Study, and Anti-Proliferative Activity of Some 2-Benzimidazolylthioacetophenones towards Triple-Negative Breast Cancer MDA-MB-468 Cells as Apoptosis-Inducing Agents.
    Abdel-Aziz HA; Eldehna WM; Ghabbour H; Al-Ansary GH; Assaf AM; Al-Dhfyan A
    Int J Mol Sci; 2016 Jul; 17(8):. PubMed ID: 27483243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of Interactions between Cisplatin and Two Histone Deacetylase Inhibitors in MCF7, T47D and MDA-MB-231 Human Breast Cancer Cell Lines - An Isobolographic Analysis.
    Wawruszak A; Luszczki JJ; Grabarska A; Gumbarewicz E; Dmoszynska-Graniczka M; Polberg K; Stepulak A
    PLoS One; 2015; 10(11):e0143013. PubMed ID: 26580554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.
    Amemiya Y; Yang W; Benatar T; Nofech-Mozes S; Yee A; Kahn H; Holloway C; Seth A
    Breast Cancer Res Treat; 2011 Apr; 126(2):373-84. PubMed ID: 20464481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of increased osteopontin and splice variant-c mRNA expression with HER2 and triple-negative/basal-like breast carcinomas subtypes and recurrence.
    Ortiz-Martínez F; Perez-Balaguer A; Ciprián D; Andrés L; Ponce J; Adrover E; Sánchez-Payá J; Aranda FI; Lerma E; Peiró G
    Hum Pathol; 2014 Mar; 45(3):504-12. PubMed ID: 24440093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relevance of using 3D cell cultures, in addition to 2D monolayer cultures, when evaluating breast cancer drug sensitivity and resistance.
    Breslin S; O'Driscoll L
    Oncotarget; 2016 Jul; 7(29):45745-45756. PubMed ID: 27304190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy.
    Kren BT; Unger GM; Abedin MJ; Vogel RI; Henzler CM; Ahmed K; Trembley JH
    Breast Cancer Res; 2015; 17():19. PubMed ID: 25837326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitamin D, tamoxifen and beta-estradiol modulate breast cancer cell growth and interleukin-6 and metalloproteinase-2 production in three-dimensional co-cultures of tumor cell spheroids with endothelium.
    Paduch R; Kandefer-Szerszeń M
    Cell Biol Toxicol; 2005; 21(5-6):247-56. PubMed ID: 16323060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Three-dimensional chitosan scaffold-based MCF-7 cell culture for the determination of the cytotoxicity of tamoxifen.
    Dhiman HK; Ray AR; Panda AK
    Biomaterials; 2005 Mar; 26(9):979-86. PubMed ID: 15369686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selection of Effective Therapies Using Three-Dimensional
    Palubeckaitė I; Venneker S; Briaire-de Bruijn IH; van den Akker BE; Krol AD; Gelderblom H; Bovée JVMG
    Front Mol Biosci; 2020; 7():566291. PubMed ID: 33425984
    [No Abstract]   [Full Text] [Related]  

  • 36. High-content assays for characterizing the viability and morphology of 3D cancer spheroid cultures.
    Sirenko O; Mitlo T; Hesley J; Luke S; Owens W; Cromwell EF
    Assay Drug Dev Technol; 2015 Sep; 13(7):402-14. PubMed ID: 26317884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Indole-3-carbinol cyclic tetrameric derivative CTet synergizes with cisplatin and doxorubicin in triple-negative breast cancer cell lines.
    De Santi M; Galluzzi L; Duranti A; Magnani M; Brandi G
    Anticancer Res; 2013 May; 33(5):1867-72. PubMed ID: 23645732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.
    Andey T; Sudhakar G; Marepally S; Patel A; Banerjee R; Singh M
    Mol Pharm; 2015 Apr; 12(4):1105-20. PubMed ID: 25661724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploration of Benzenesulfonamide-Bearing Imidazole Derivatives Activity in Triple-Negative Breast Cancer and Melanoma 2D and 3D Cell Cultures.
    Balandis B; Mickevičius V; Petrikaitė V
    Pharmaceuticals (Basel); 2021 Nov; 14(11):. PubMed ID: 34832940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tryptophan hydroxylase 1 and 5-HT
    Gautam J; Banskota S; Regmi SC; Ahn S; Jeon YH; Jeong H; Kim SJ; Nam TG; Jeong BS; Kim JA
    Mol Cancer; 2016 Nov; 15(1):75. PubMed ID: 27871326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.